Canji

Canji, Inc. was established to commercialize tumor suppressor gene technology developed by Dr. Wen-Hwa Lee of the University of California, San Diego. Canji is a subsidiary of Merck & Co., Inc. The company is dedicated to developing innovative therapies based on tumor suppressor genes, cell cycle regulators, and growth factors.